Globeflex Capital’s NxStage Medical Inc. NXTM Stock Holding History

Globeflex Capital’s Portfolio NXTM Stock Details NXTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-52,200	Closed	-$1.37M	–	603
2016 Q4	$1.37M	Sell	52,200 -800	-2%	-$19.8K	0.34%	101
2016 Q3	$1.32M	Hold	53,000	–	–	0.33%	96
2016 Q2	$1.15M	Hold	53,000	–	–	0.31%	111
2016 Q1	$794K	Sell	53,000 -3,700	-7%	-$62K	0.21%	167
2015 Q4	$1.24M	Sell	56,700 -200	-0.4%	-$3.73K	0.33%	93
2015 Q3	$897K	Buy	+56,900	New	+$912K	0.19%	182

Other funds holding NXTM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

PCM

Pennant Capital Management Summit, New Jersey $212M AUM 19.37% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Globeflex Capital's NXTM Position: Q1 2017 in Review

Globeflex Capital sold out of NxStage Medical Inc. (NXTM) in Q1 2017, closing a stake of 52,200 shares — an estimated $1.37M sold.

Globeflex Capital first reported a position in NXTM in Q3 2015 and held it in 6 quarters. The position peaked at $1.37M in Q4 2016. 171 funds tracked by Wall St. Rank hold NXTM as of Q1 2017.

Globeflex Capital reported no remaining NxStage Medical Inc. position as of Q1 2017 after selling out during the quarter.
Globeflex Capital sold 52,200 NxStage Medical Inc. shares in Q1 2017, an estimated $1.37M.
Globeflex Capital first reported a position in NxStage Medical Inc. in Q3 2015 and held it in 6 quarters.
Globeflex Capital's NxStage Medical Inc. position peaked at $1.37M in Q4 2016.
171 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2017.

Based on Globeflex Capital's 13F filing for Q1 2017, filed 12 May 2017.